搜索筛选:
搜索耗时0.0749秒,为你在为你在102,285,761篇论文里面共找到 3 篇相符的论文内容
发布年度:
Long-term survival of more than 3 years among patients with advanced non-small cell lung cancer trea
[期刊论文] 作者：Rieko Kaira,Kyoichi Kaira,Takehito Shukuya,Hirotsugu Kenmotsu,Akira Ono,Haruyasu Murakami,Asuka Tsuya,
来源：World Journal of Respirology 年份：2013
AIM: To evaluate the prognostic factors of long-term survival of more than 3 years in patients with advanced non-small cell lung cancer(NSCLC). METHODS: We retr...
Randomized trial of gefitinib with and without pemetrexed as first-line therapy in East-Asian patien
[会议论文] 作者：Ying Cheng,Haruyasu Murakami,Pan-Chyr Yang,Jianxing He,Kazuhiko Nakagawa,Jin Hyoung Kang,Joo-Hang Kim,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
目的： Pemetrexed (P) is the standard of care for non-squamous non-small cell lung cancer (NS NSCLC)， whereas epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs)， such as gefitinib...
A phase Ⅱ open-label single-arm study of vandetanib in patients with advanced RETrearranged non-smal
[会议论文] 作者：Takashi Seto,Kiyotaka Yoh,Miyako Satouchi,Makoto Nishio,Noboru Yamamoto,Haruyasu Murakami,Naoyuki Nogami,
来源：2016年临床肿瘤学新进展学术研讨会 年份：2016
...
相关搜索：
